Loading…

Boehringer Ingelheim will invest 1.6 billion Mexican pesos ($84 million) by 2023 to expand its three manufacturing sites in Mexico, starting with a $52 million investment at its Xochimilco site to boost tablet production capacity.
“The goal is to increase production to 2.5 billion tablets annually in 2028 from about 1.6 billion tablets now.”fiercepharma.com
Summarized from public sources; check the original articles before acting on it.